BiondVax Pharmaceuticals Ltd ADR
Biotechnology
Healthcare
BVXV
754 B shares
NASDAQ US
traded
06 Sep 2023
listed
yes
open
1.32
52 week high
10.96
high
1.37
52 week low
1.32
low
1.32
growth
-82.43 %
previous Close
1.35
P/E ratio
market cap
4.73 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top